Is self-diagnosis valid?

The question hides two questions

Most arguments about self-diagnosis go badly because the two sides are answering different things.

The first question is about accuracy: if someone concludes they’re autistic or have ADHD without a clinician, how often are they right? That’s empirical, but the available comparison studies don’t answer it directly.

The second is about legitimacy: are they entitled to use the word, join the community, and be taken seriously? That’s partly about values, and partly about who has access to assessment in the first place.

Conflating them produces bad arguments in both directions. “Self-diagnosis is valid because gatekeeping is harmful” answers the second question while ignoring the first. “Self-diagnosis is invalid because only clinicians can diagnose” answers neither, since it assumes the conclusion. Taking them separately gets further.

The wording is worth a note before going further. Researchers and community writers increasingly say self-identification instead of self-diagnosis, because “diagnosis” implies a clinical act that hasn’t happened. The distinction is useful, and it’s the language used through the rest of this page.

What the research can and can’t say about accuracy

The available work complicates dismissive accounts of self-identification, but it doesn’t provide an accuracy rate.

One scope limit matters: the comparison research below concerns autism. It cannot be assumed to show how accurately adults self-identify ADHD.

An online structural comparison of 893 adults reporting a formal diagnosis and 245 self-identified adults found broadly similar autism-related identity, stigma, self-esteem, and quality of life between the groups. The author explicitly noted that the study could not determine whether the self-identified participants met autism criteria (McDonald, 2020). A 2024 psychometric study of 839 adults across self-reported diagnosed, self-identified, exploring, and non-autistic groups found few differences in how diagnosed and self-identifying participants responded to the RAADS-R and RAADS-14 (Sturm et al., 2024). It tested the measures’ item functioning, not the participants against a clinical diagnostic standard.

A 2024 scoping review of 13 studies, all based on online data, found referral barriers and some similarities between diagnosed and self-identified adults on particular measures (Overton et al., 2024). It also recorded differences on some measures and did not clinically verify self-identified participants. Similarity is meaningful, but it isn’t the same thing as diagnostic accuracy.

Undiagnosed autism also isn’t a rare edge case. An exploratory projection based on English primary-care records and assumed population prevalence estimated that 59% to 72% of autistic people in England may have been undiagnosed in 2018, with the gap concentrated in adults and especially older adults (O’Nions et al., 2023). That shows that autistic people can remain undiagnosed. It does not show whether any particular self-identifying person meets the criteria.

Why so many people self-identify

In self-selected online studies, some adults describe self-identifying while encountering barriers to assessment. That documents a recurring experience in those samples, not the main reason every self-identifying adult takes that path.

The barriers are documented, though the evidence comes largely from self-selected online samples. Adults in those studies report long waiting lists, the cost of private assessment, general practitioners acting as referral gatekeepers, fear of not being believed, and a lack of trust in healthcare professionals (Lewis, 2017). Qualitative work on receiving or realising an autism diagnosis in adulthood also describes an emotional process of re-reading a lifetime of experiences (Lewis, 2016).

The waits are real and measurable. A 2025 retrospective study of 202 completed adult-service cases from volunteer teams across participating Scottish health boards in 2021–22 found a median wait of 252 days from referral to the written outcome (Maciver et al., 2025). That figure describes a particular historical Scottish sample, not a universal or current wait. Figures differ by country, service, and system.

Framed that way, a lot of the heat goes out of the argument. Someone who has waited two years, been turned down for a referral, or been quoted more than a month’s rent for a private assessment hasn’t necessarily opted out of the clinical route. Access may be the obstacle.

What self-identification doesn’t do

Being clear about this is what makes the rest of the page trustworthy.

Self-identification isn’t a clinical report, and some institutions and services do require documentation. The rules are not universal. In the United States, the Equal Employment Opportunity Commission, the federal agency that enforces workplace disability law, says an employer may ask for reasonable documentation when a disability or the need for an accommodation isn’t obvious, but a formal diagnosis is not required in every case (EEOC). In the United Kingdom, Acas, the public workplace advice service, states that a worker does not need a diagnosis to be considered disabled under the Equality Act 2010 and that employers should offer support whether or not someone has one (Acas). Universities, insurers, and individual programs set their own evidence rules.

Prescription access also depends on what you mean. ADHD medication requires assessment and diagnosis by an appropriate clinician. For autism, NICE, which sets clinical guidance for the NHS in England and Wales, recommends against using medication to manage the core features in adults, though clinicians may treat coexisting conditions (NICE).

It also can’t rule anything out. Traits overlap across a lot of conditions, and some experiences that read as autism or ADHD have other explanations, including ones with specific treatments. Concluding “this is autism” closes a question that a clinician would keep open. That’s a genuine cost, and it’s the strongest argument on the sceptical side.

An editorial weighing the costs and benefits of a formal autism diagnosis frames the whole thing as this trade-off, not as one option being more legitimate than the other (Fletcher-Watson, 2024). That’s the right shape for the decision.

Where the disagreement is real

Some of this isn’t settled, and flattening it would be a disservice.

Researchers disagree about whether self-identified participants should be pooled with diagnosed ones in studies. The case for inclusion is that excluding them systematically removes the people least able to access assessment, which biases findings toward whoever can afford a private appointment. The case against is that diagnostic confirmation is what makes a sample mean something, and that small measured differences between the groups may matter more than they appear.

There’s also an unresolved argument about what happens to a category when identification becomes widespread. Some clinicians worry about traits being over-attributed to a single explanation. Some community advocates reply that the same concern is rarely raised about conditions that carry less stigma, and that the historical error ran the other way for decades. Both positions have something to them.

The comparison studies don’t justify treating self-identified adults as interchangeable with clinically diagnosed samples, but they also don’t support dismissing them as a group. Without clinical verification, those studies cannot tell us how often self-identification is right or wrong.

How to hold it

Here’s a workable position, given all of the above.

Use self-identification for what it’s good for: understanding your own history, finding community, and applying strategies that help. None of that requires anyone’s permission, and none of it requires claiming clinical certainty.

Keep the question open instead of closed. “This is the best explanation I have, and I’d like it checked when I can” is more accurate than either “I’m autistic, full stop” or “I can’t say anything until a clinician does.” It also leaves room for the answer to change.

Find out what evidence your specific situation requires. ADHD medication means clinical assessment. Workplace and academic accommodation rules differ by institution and jurisdiction, so ask before assuming either that self-identification is enough or that a full diagnostic report is mandatory.

Whether that’s worth pursuing is its own decision with real costs on both sides. If you’re worried you have no childhood documentation to bring, that’s a smaller obstacle than it looks. And if you want a structured way to think it through first, the NeuroDiversion AuDHD self-reflection is built for that. Self-identification is a reasonable place to stand. It can’t do the specific things a formal diagnosis does, which is the trade-off worth being clear-eyed about.